Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Demand Spike Sees Sandoz, Teva Fall Short On US Amoxicillin Supply

‘We Are Working To Manage Situation,’ Sandoz Tells Generics Bulletin

Executive Summary

Infants and young children across the US are continuing to struggle to get access to one of the most common and recognized antibiotics, liquid-dose amoxicillin, amid a surge in demand for the drug that has hindered generics manufacturers.

You may also be interested in...



US Shortages Bite Again As Oseltamivir Dries Up Amid Winter Flu Season

Another commonly prescribed generic in the US has fallen to shortages, as the country battles with a particularly fierce winter flu season.

To Prevent Shortages, US FDA Wants Sponsor To Provide Notifications Of Demand Spike

Demand-related shortages are a relatively new problem, but the FDA maintains their tools can prevent or end them.

To Prevent Shortages, US FDA Wants Notices From Drug Firms On Spikes In Demand

Demand-related shortages are a relatively new problem, but FDA maintains its tools can prevent or end them.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

GB152340

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel